CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 60,146	$ 74,103
Accounts receivable, net	3,563	3,543
Other current assets	5,338	5,639
Total current assets	69,047	83,285
Property and equipment, net	3,702	2,407
Intangible assets, net	30,687	30,793
Goodwill	13,074	13,074
Other assets	1,694	1,692
Total assets	118,204	131,251
Current liabilities:
Accounts payable	1,065	332
Accrued expenses	12,052	9,212
Other current liabilities	312	185
Total current liabilities	13,429	9,729
Contingent consideration liability	19,600	18,800
Deferred tax liability	11,199	11,199
Other liabilities	138	862
Total liabilities	44,366	40,590
Stockholders' equity:
Preferred stock, $0.001 par value; Authorized - 20,000 shares; issued and outstanding - none	0	0
Common stock, $0.0013 par value; Authorized - 160,000 shares; issued - 70,148 shares in 2016 and 70,146 shares in 2015	91	91
Additional paid-in capital	596,058	594,511
Treasury stock at cost, 200 shares of common stock	(2,741)	(2,741)
Accumulated other comprehensive loss	(64)	(26)
Accumulated deficit	(519,672)	(501,379)
Total Progenics stockholders' equity	73,672	90,456
Noncontrolling interests	166	205
Total stockholders' equity	73,838	90,661
Total liabilities and stockholders' equity	$ 118,204	$ 131,251